Anti-cancer activity of two novel heterocyclic compounds through modulation of VEGFR and miR-122 in mice bearing Ehrlich ascites carcinoma
Reem M. Hazem, Anhar A. Mohamed, Nagat Ghareb, Eman T. Mehanna, Noha M. Mesbah, Dina M. Abo‐Elmatty, Mohamed Saleh Elgawish
Topics & Concepts
Ehrlich ascites carcinomaAngiogenesisCisplatinMetastasisCancerVascular endothelial growth factorAscitesMedicineCarcinomaCreatinineInternal medicineBreast carcinomaChemotherapyBreast cancerPathologyCancer researchEndocrinologyVEGF receptorsTumor cellsQuinazolinone synthesis and applicationsAngiogenesis and VEGF in CancerCytokine Signaling Pathways and Interactions